Nucleus of the Pharmaceutical Industry

Generic pharmaceutical companies sometimes do employ organic chemists as process chemists. To appreciate this situation, imagine that a Fipco s compoimd patent expires, depriving a valuable medicine of further composition-of-matter protection. Also suppose that a separate process patent still protects the originator s commercial synthesis. In these circumstances, the generic firm wishing to sell this medicine is free to do so if its 

Drug Discovery Firms and Start-Up Pharmaceutical Companies 

---